Treatment of Functional Dyspepsia (Indigestion) with Unani medicine Majoone-Sangdana Murgh
- Conditions
- Health Condition 1: K30- Functional dyspepsia
- Registration Number
- CTRI/2019/02/017801
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
· Patients of either sex in the age group of 18-60
· Patients meeting the Rome III diagnostic criteria for PDS
· Presence of GI ulcer, erosive gastritis, atrophic gastritis, severe dysplasia of gastric mucosa
or suspicious malignant lesion.
· Having overlap syndrome combined with gastro esophageal reflux disease or irritable
bowel syndrome
· Having alarm symptoms (weight loss, black or tar stool, dysphasia, etc.)
· Having any systemic disease (diseases of heart, lung, liver or kidney) or mental illness
· History of surgery related with the gastrointestinal tract more than six months ago
· Taking drugs which may affect the gastro intestinal tract, such as non-steroidal antiinflammatory
drugs and aspirin
· Known Allergy to the experimental medications
· Pregnant and breastfeeding
· Refusing to sign the informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptoms of Duâ??f al-Miâ??da (Functional Dyspepsia)Timepoint: 6 weeks
- Secondary Outcome Measures
Name Time Method Investigations will be done at baseline and end of treatmentTimepoint: 6 weeks